0.10%QQQQ 44.63 
0.18%XLF 19.94 0.35%
Digg
Del.icio.us
Newsvine 
Facebook
Stumbleupon
NEW YORK (AP) - Pfizer Inc. late Wednesday said that it named Garry A. Nicholson to head the drug maker's new oncology business unit.
Nicholson's responsibilities within the franchise include clinical development, commercial development, sales and marketing.
According to Pfizer, the oncology market is expected to double in the next decade.
Prior to joining Pfizer, Nicholson served as global oncology platform leader at Eli Lilly and Co. He also was executive director of Lilly's U.S. oncology business unit for more than 10 years.
Shares of Pfizer closed Wednesday at $20.06.
I recently read an "advotorial" suggesting silver to be a fantastic investment, and I could not agree more. However, the author was stating that ...
A homemade bomb tore through a crowd that included the country's authoritarian p...
A hedge fund cheat who tried to fake his own death and spent nearly a month as a...
|
Find the most up to date research from leading investment firms to make the most informed investing decisions
Professional Website Design For Corporate - Get a Free Quote Today
Partners  
|
© 2008 The Ibtimes Company. All Rights Reserved. Terms of service | Privacy Policy | Advertising | About Us | Contact Us | Archives
EMAIL
PRINT
RSS
SHARE
0.13
